|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Pacira BioSciences (NASDAQ: PCRX) through any online brokerage.
The latest price target for Pacira BioSciences (NASDAQ: PCRX) was reported by Needham on October 18, 2021. The analyst firm set a price target for 84.00 expecting PCRX to rise to within 12 months (a possible 62.60% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Pacira BioSciences (NASDAQ: PCRX) is $51.66 last updated Wed Oct 27 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Pacira BioSciences.
Pacira BioSciences’s $Q3 earnings are confirmed for after-market on $November 3, 2021.
There is no upcoming split for Pacira BioSciences.
Pacira BioSciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.